NanoCell Therapeutics is a privately-held biotechnology company with offices in King of Prussia, Pennsylvania, and Utrecht, the Netherlands. Our mission is to revolutionize in-vivo cell engineering through our groundbreaking non-viral, DNA-based gene therapy platform, primarily focusing on oncology and autoimmune diseases. At NanoCell, we’re driving innovation by transforming traditional adoptive cell therapy methods into advanced in-vivo treatments. Our ultimate goal is to simplify the treatment process, increasing patient accessibility, potential clinical benefits, and cost-effective manufacturing. We work both autonomously and in collaboration with partners to make substantial advancements in our targeted disease areas. For more information, visit http://www.nanocelltx.com).
Company Details
- Employees
- 16
- Address
- Bolognalaan, Utrecht,netherlands
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://nanocelltx.com
- HQ
- Utrecht
Nanocell Therapeutics Questions
Nanocell Therapeutics's website is http://nanocelltx.com
Nanocell Therapeutics's LinkedIn profile is https://nl.linkedin.com/company/nanocell-tx
Nanocell Therapeutics has
16 employees.
View email and phone details for 16
employees at Nanocell Therapeutics.
Nanocell Therapeutics's industry is
Pharmaceutical Manufacturing
Nanocell Therapeutics's top competitors are
Kelonia Therapeutics,
Nano-Engine,
Interius Biotherapeutics,
Orna Therapeutics,
Myeloid Therapeutics,
Nanospresso-Nl,
Carisma Therapeutics,
Alaya.bio,
Umoja Biopharma,
Capstan Therapeutics.
Nanocell Therapeutics's categories are Pharmaceutical Manufacturing
